Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trial
Titel:
Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trial
Auteur:
Confavreux, Christian O'Connor, Paul Comi, Giancarlo Freedman, Mark S Miller, Aaron E Olsson, Tomas P Wolinsky, Jerry S Bagulho, Teresa Delhay, Jean-Luc Dukovic, Deborah Truffinet, Philippe Kappos, Ludwig